Chronic myeloid leukaemia - asciminib or ponatinib - initial authority application form (PB171)

Use this form to apply for initial PBS-subsidised treatment with asciminib or ponatinib for chronic myeloid leukaemia.

Page last updated: 18 June 2024.
QC 21441